Douglas E Berning

Title: Douglas E. Berning: Innovator in Hydroxymethyl Phosphine Compounds

Introduction

Douglas E. Berning is a notable inventor based in Columbia, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on hydroxymethyl phosphine compounds. With a total of 4 patents, Berning's research has the potential to impact diagnostic and therapeutic applications.

Latest Patents

One of Berning's latest patents is focused on hydroxymethyl phosphine compounds for use as diagnostic and therapeutic agents. This patent describes a compound and method for creating a pharmaceutical that includes at least one functionalized hydroxyalkyl phosphine donor group, along with sulfur or nitrogen donor groups and a metal combined with the ligand. Another significant patent involves a method for forming aminomethyl phosphorus conjugates. This method includes reacting a hydroxymethyl phosphine group of an amine-free first molecule with a free amine group of a second molecule, resulting in a covalent bond through an aminomethyl phosphorus linkage.

Career Highlights

Douglas E. Berning is affiliated with the University of Missouri, where he conducts his research and development. His work has garnered attention for its innovative approach to pharmaceutical compounds, showcasing his expertise in the field.

Collaborations

Some of Berning's notable coworkers include Kattesh V. Katti and Wynn A. Volkert. Their collaborative efforts contribute to the advancement of research in the area of phosphine compounds.

Conclusion

Douglas E. Berning's contributions to the field of pharmaceuticals through his patents on hydroxymethyl phosphine compounds highlight his role as an influential inventor. His work continues to pave the way for advancements in diagnostic and therapeutic applications.